title: Treatment of multiple sclerosis and other autoimmune diseases with cladribine.
authors.affiliation: Department of Molecular and Experimental Medicine, Scripps Clinic and Research Foundation, La Jolla, CA, USA.
authors.forename: E
authors.initials: E
authors.lastname: Beutler
authors.forename: J
authors.initials: J
authors.lastname: Sipe
authors.forename: J
authors.initials: J
authors.lastname: Romine
authors.forename: R
authors.initials: R
authors.lastname: McMillan
authors.forename: J
authors.initials: J
authors.lastname: Zyroff
authors.forename: J
authors.initials: J
authors.lastname: Koziol
mesh_terms: D000704:Analysis of Variance; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000473:pathology; D017338:Cladribine / Q000009:adverse effects / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006403:Hematologic Tests; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology; D009460:Neurologic Examination; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy
chemical_list: D007166:Immunosuppressive Agents; D017338:Cladribine